A NEW one-minute cancer drug injection will speed up treatment for thousands of NHS patients. The medicine pembrolizumab, aka ...

The Department of Health says it is "aware" of the jab and is "exploring" how it can be made available "as soon as possible".

(Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial ...

Radiation therapy combined with Keytruda increased T cell infiltration in HR+ and HER2-negative breast cancer, enhancing immune response. High-dose radiation with Keytruda led to increased ...

Shirley Xerxes was one of the first in the UK to receive the injectable form of Keytruda on the NHS A new injectable form of ...

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

Merck & Co.’s Keytruda has become the first immunotherapy approved by the FDA to be used around surgery to treat resectable locally advanced head and neck cancer. But the breakthrough approval ...

PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder ...